|
US2007015733A1
|
|
Aryl Phosphate Derivatives of d4T having Activity Against Resistant HIV Strains
|
|
US2006046972A1
|
|
Cytotoxic nucleoside analog compound 003 for treating cancer
|
|
WO2004066959A2
|
|
Organic-arsonic compounds
|
|
AU2003253657A1
|
|
Pokeweed antiviral protein polypeptides with antiviral activity
|
|
WO03105863A1
|
|
Aryl phosphate derivatives with selective activity against adenovirus and hiv
|
|
US2004034045A1
|
|
Inhibitors of thrombin induced platelet aggregation
|
|
US2003186991A1
|
|
Phenoxyethyl-thiourea-pyridine compounds and their use for treatment of HIV-infections
|
|
US2003207921A1
|
|
Adamantyl Thiazole Thioureas
|
|
US7144874B2
|
|
Aryl phosphate derivatives of d4T having activity against resistant HIV strains
|
|
WO03016338A1
|
|
Crystal structure of the btk kinase domain
|
|
US6482828B1
|
|
4-(4'-hydroxyphenyl) amino-6,7-dimethoxyquinazoline to prevent development of colorectal cancer
|
|
US6734207B2
|
|
Cytotoxic compounds
|
|
US2002169207A1
|
|
Inhibiting collagen-induced platelet aggregation
|
|
US6689793B2
|
|
Piperidinylethyl-, phenoxyethyl-, and β-fluorophenethyl-substituted thiourea compounds with potent anti-HIV activity
|
|
US6825177B2
|
|
Aryl phosphate derivatives of d4T with potent anti-viral activity
|
|
AU9119501A
|
|
Nucleotide and protein sequence of helios 3 and methods of use
|
|
US7064114B2
|
|
Gel-microemulsion formulations
|
|
US2001051629A1
|
|
Lipid lowering quinazoline dietary supplement composition
|
|
AU4792201A
|
|
Calpain inhibitors in cancer treatment
|
|
WO0243735A1
|
|
Inhibitors of thrombin induced platelet aggregation
|
